BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6758256)

  • 1. Intracytoplasmic lysozyme in malignant hematologic disorders: an immunoperoxidase study.
    Tabilio A; Falini B; Aversa F; Zuccaccia M; Cernetti C; Gerli R; Rutili D; Grignani F; Martelli MF
    Tumori; 1982 Oct; 68(5):417-25. PubMed ID: 6758256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of intracytoplasmic lysozyme in normal tissues, myeloproliferative disorders, hairy cell leukemia, and other pathologic processes. An immunoperoxidase study of paraffin sections and smears.
    Pinkus GS; Said JW
    Am J Pathol; 1977 Nov; 89(2):351-66. PubMed ID: 335890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of lysozyme determination in hematological practice].
    Zittoun R; Zittoun J
    Nouv Presse Med; 1974 Jul; 3(27):1709-10. PubMed ID: 4602603
    [No Abstract]   [Full Text] [Related]  

  • 4. Utilization of cytoplasmic lysozyme immunoreactivity as a histiocytic marker in canine histiocytic disorders.
    Moore PF
    Vet Pathol; 1986 Nov; 23(6):757-62. PubMed ID: 3027941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muramidase activity in leukemia and myeloproliferative disorders.
    Skarin AT; Matsuo Y; Moloney WC
    Oncology; 1973; 27(5):406-14. PubMed ID: 4515747
    [No Abstract]   [Full Text] [Related]  

  • 6. [Applications of the peroxidase-anti-peroxidase technique in dermatology (author's transl)].
    Rauch HJ; Kerl H; Kresbach H
    Wien Klin Wochenschr; 1981 Sep; 93(16):512-4. PubMed ID: 6272500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies.
    Wiernik PH; Serpick AA
    Am J Med; 1969 Mar; 46(3):330-43. PubMed ID: 4888852
    [No Abstract]   [Full Text] [Related]  

  • 8. Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells.
    Mertelsmann R; Moore MA; Clarkson B
    Haematol Blood Transfus; 1981; 26():68-72. PubMed ID: 6947940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum lysozyme in some haematological diseases (author's transl)].
    Bláha M; Procházková J; Wagenknecht D; Vanásek J; Siroký O
    Cas Lek Cesk; 1978 Jul; 117(27):827-9. PubMed ID: 278647
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular lysozyme and lactoferrin in myeloproliferative disorders.
    Mason DY
    J Clin Pathol; 1977 Jun; 30(6):541-6. PubMed ID: 326818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoproliferative and myeloproliferative disorders.
    Savage CJ
    Vet Clin North Am Equine Pract; 1998 Dec; 14(3):563-78, vii. PubMed ID: 9891725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical observation of intracytoplasmic lysozyme in proliferative and neoplastic fibrohistiocytic lesions.
    Nakanishi S; Shinomiya S; Sano T; Hizawa K
    Acta Pathol Jpn; 1982 Nov; 32(6):949-59. PubMed ID: 6297236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peanut agglutinin: a new marker for tissue histiocytes.
    Howard DR; Batsakis JG
    Am J Clin Pathol; 1982 Apr; 77(4):401-8. PubMed ID: 7041617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and patterns of muramidase containing cells in Hodgkin's disease, non-Hodgkin's lymphomas, and reactive hyperplasia.
    Ree HJ; Song JY; Leone LA; Crowley JP; Fanger H
    Hum Pathol; 1981 Jan; 12(1):49-59. PubMed ID: 6162773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lysozyme activity in some myeloproliferative diseases.
    Merkiel K; Prokopowicz J; Bielawiec M; Kiersnowska B
    Haematologia (Budap); 1977; 11(1-2):111-4. PubMed ID: 276510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial myeloperoxidase deficiency.
    Cech P; Schneider P; Bachmann F
    Acta Haematol; 1982; 67(3):180-4. PubMed ID: 6282028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in normal hematopoietic cells and in myeloid leukemias: an immunoperoxidase study on cytocentrifuge preparations, smears, and paraffin sections.
    Krugliak L; Meyer PR; Taylor CR
    Am J Hematol; 1986 Jan; 21(1):99-109. PubMed ID: 3518416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytological demonstration of lysozyme (muramidase) in human leukaemic cells.
    Asamer H; Schmalzl F; Braunsteiner H
    Br J Haematol; 1971 Jun; 20(6):571-4. PubMed ID: 4932959
    [No Abstract]   [Full Text] [Related]  

  • 19. An immunohistochemical study of hemoglobin A, hemoglobin F, muramidase, and transferrin in erythroid hyperplasia and neoplasia.
    Forni M; Meyer PR; Levy NB; Lukes RJ; Taylor CR
    Am J Clin Pathol; 1983 Aug; 80(2):145-51. PubMed ID: 6192699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice overexpressing arginase 1 in monocytic cell lineage are affected by lympho-myeloproliferative disorders and disseminated intravascular coagulation.
    Astigiano S; Morini M; Damonte P; Fraternali Orcioni G; Cassanello M; Puglisi A; Noonan DM; Bronte V; Barbieri O
    Carcinogenesis; 2015 Nov; 36(11):1354-62. PubMed ID: 26363032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.